| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/22/1998 | EP0836475A1 Controlled release formulations for poorly soluble drugs |
| 04/22/1998 | EP0836472A1 Therapeutic effervescent compositions |
| 04/22/1998 | EP0820285A4 Methods and compositions for lipidization of hydrophilic molecules |
| 04/22/1998 | EP0796403A4 Functionalized nanotubes |
| 04/22/1998 | EP0746294A4 Absorption enhancers for topical pharmaceutical formulations |
| 04/22/1998 | EP0724564B1 Use of terminal group capped fatty acid amide alkoxylates |
| 04/22/1998 | EP0627913B1 Facilitated oxygen delivery in conjunction with hemodilution |
| 04/22/1998 | EP0515460B1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/22/1998 | CN1179725A Modulation of cell proliferation and wound healing |
| 04/22/1998 | CN1179724A HCG Liquid formulations |
| 04/22/1998 | CN1179721A Novel pharmacetical formulation |
| 04/22/1998 | CN1179720A Corticosteroid-containing pharmaceutical compositions |
| 04/22/1998 | CN1179718A Novel pharmaceutical composition |
| 04/22/1998 | CN1179717A Novel pharmaceutical composition |
| 04/22/1998 | CN1179330A Skin carrier protective tissue matrix and preparing process thereof |
| 04/22/1998 | CN1179307A Liquid antiacid compositions |
| 04/22/1998 | CA2217550A1 Cationic lipids for gene therapy |
| 04/21/1998 | US5741893 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 04/21/1998 | US5741891 Pulmonary surfactant peptide solubilization process |
| 04/21/1998 | US5741822 Mixed lipid-bicarbonate colloidal particles for delivering drugs |
| 04/21/1998 | US5741806 Suppository compositions containing ondasetron dihydrate |
| 04/21/1998 | US5741692 Used in compositions for selectively and completely disinserting vitreous body from neural retina of an eye |
| 04/21/1998 | US5741680 Buffer composition base and method of formulation for oral vaccine delivery |
| 04/21/1998 | US5741670 Polypeptides |
| 04/21/1998 | US5741600 Absorbable coating and blend |
| 04/21/1998 | US5741551 Preparation of polymeric surfaces |
| 04/21/1998 | US5741525 Vaginal pharmaceutical hydrogen peroxide composition |
| 04/21/1998 | US5741524 Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility |
| 04/21/1998 | US5741523 Stabilized prostaglandin E1 |
| 04/21/1998 | US5741515 Reaction product of phosphates and ketoprofen |
| 04/21/1998 | US5741512 Pharmaceutical compositions comprising cyclosporins |
| 04/21/1998 | US5741507 Ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
| 04/21/1998 | US5741495 Glucan drug delivery system and adjuvant |
| 04/21/1998 | US5741478 Preparation of hollow microcapsules by spray-drying an aqueous solution of a wall-forming material and a water-miscible solvent |
| 04/21/1998 | US5740793 Dry powder inhalation device with elongate carrier for power |
| 04/21/1998 | CA2106400C Polyamino acid dispersants |
| 04/21/1998 | CA2022465C Process for micronizing slightly-soluble drug |
| 04/16/1998 | WO1998015639A1 Method for preparing compositions for transferring nucleic acids |
| 04/16/1998 | WO1998015620A1 Polymer-protein composites and methods for their preparation and use |
| 04/16/1998 | WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | WO1998015293A2 Targeted addition of soluble polymers to recombinant proteins |
| 04/16/1998 | WO1998015292A1 Viscous hemostatic composition, in particular in gel state |
| 04/16/1998 | WO1998015291A1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 04/16/1998 | WO1998015268A1 Pharmaceutical microspheres of valproic acid for oral administration |
| 04/16/1998 | WO1998015265A1 Colonic delivery of weak acid drugs |
| 04/16/1998 | WO1998015264A1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN |
| 04/16/1998 | WO1998015196A1 Compositions for postgastrectomic mineral supply |
| 04/16/1998 | DE19640791A1 Glycokonjugate als Inhibitoren der viralen Zelladhäsion Glycoconjugates as inhibitors of viral cell adhesion |
| 04/16/1998 | CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | CA2268261A1 Polymer-protein composites and methods for their preparation and use |
| 04/16/1998 | CA2267187A1 Method for preparing compositions for transferring nucleic acids |
| 04/16/1998 | CA2264637A1 Colonic delivery of weak acid drugs |
| 04/15/1998 | EP0835862A1 Partial esters of polyglycerine with fatty acids and polyfunctional carbonylic acids, their preparation and use |
| 04/15/1998 | EP0835663A2 Combined vaccines comprising Hepatitis B surface antigen and other antigens |
| 04/15/1998 | EP0835657A1 Injectable composition |
| 04/15/1998 | EP0835654A1 Glucomannan-containing orally administered pharmaceutical preparations with sustained effect |
| 04/15/1998 | EP0835652A1 Use of at least one glycol in the solubilisation of melatonin in water and compositions containing them |
| 04/15/1998 | EP0835650A1 Use of oxazolidinon derivatives as antipenetrant agents in a cosmetic and/or dermatologic composition |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835266A1 Modified/chimeric superantigens and their use |
| 04/15/1998 | EP0835262A1 Method for the treatment of corticosteroid induced osteopenia |
| 04/15/1998 | EP0835252A1 Triazole antifungal agents |
| 04/15/1998 | EP0835136A2 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
| 04/15/1998 | EP0835134A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
| 04/15/1998 | EP0835124A1 Serum preparations for inhibiting retroviruses and tumor growth |
| 04/15/1998 | EP0835105A1 Pharmaceutical amiodarone composition for parenteral delivery |
| 04/15/1998 | EP0835098A1 New, stable medicinal compositions for generating propellant-free aerosols |
| 04/15/1998 | EP0835095A1 Stable topical compositions |
| 04/15/1998 | EP0821686A4 Novel porphyrins and porphyrin synthesis techniques |
| 04/15/1998 | EP0772436A4 Incorporation of biologically active molecules into bioactive glasses |
| 04/15/1998 | EP0696200A4 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 04/15/1998 | EP0674524B1 Stable lyophilized pharmaceutical preparations g-csf |
| 04/15/1998 | EP0665745B1 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same |
| 04/15/1998 | EP0640130B1 Chimeric multivalent protein analogues and methods of use thereof |
| 04/15/1998 | CN1179107A Dried blood factor composition comprising trehalose |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1179102A Oral 2 -methyl -thieno -benzodiazepine formulation |
| 04/15/1998 | CN1179100A Valaciclovir bablets containing colloidal silicon dioxide |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739350 CC-1065 analogs |
| 04/14/1998 | US5739210 Polymers comprising reversible hydrophobic functionalities |
| 04/14/1998 | US5739208 Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| 04/14/1998 | US5739195 Addition polymerizing in a water soluble protective polymeric colloids |
| 04/14/1998 | US5739176 Dissolving biocompatible water-insoluble biodegradable thermoplastic polymer in water-soluble organic solvent, placing in implant site in body, allowing solvent to diffuse or dissipate into body fluid so polymer coagulates to solid |
| 04/14/1998 | US5739122 Dextran esters, the preparation thereof and the use thereof for coating or embedding drugs |
| 04/14/1998 | US5739121 Fluorocyclosaccharide drug delivery systems |
| 04/14/1998 | US5739116 Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 04/14/1998 | US5739108 Nonaqueous composition comprising somatotropin polypeptide, biocompatible oil; sustained release |
| 04/14/1998 | US5739105 Immunosuppressive agents |
| 04/14/1998 | US5739102 Wound healing |
| 04/14/1998 | US5739020 Hydrolyzing in acid aqueous solution to form a sol-gels |
| 04/14/1998 | US5739011 DNA for the production of multimeric hemoglobins |
| 04/14/1998 | US5738984 Kits and methods of detection using cellulose binding domain fusion proteins |
| 04/14/1998 | US5738876 Method of solution overcoating with gelling polymer |
| 04/14/1998 | US5738872 Antiallergens, antihistamines; bioavailability |
| 04/14/1998 | US5738869 Mixture of active material, phospholipid, alcohol and vitamin e |
| 04/14/1998 | US5738867 Antigen encapsulated or conjugated to liposome carrier; antitumor agents |
| 04/14/1998 | US5738865 Controlled release insufflation carrier for medicaments |
| 04/14/1998 | US5738864 Drug delivery agents incorporating mitomycin |
| 04/14/1998 | US5738856 Mixture of mineral oil and reaction product of a triglyceride abd phospholipid |